SPX5,638.94+117.42 2.13%
DIA415.36+6.58 1.61%
IXIC17,754.09+451.07 2.61%

Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3

Benzinga·05/29/2024 21:20:31
Listen to the news

 Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.